Alembic Ltd.
| BSE: 506235 | Sector: Health care |
| NSE: ALEMBICLTD | ISIN Code: INE426A01027 |
| BSE 00:00 | 26 Feb | 101.75 |
-0.95 (-0.93%) |
OPEN
102.20 |
HIGH
107.00 |
LOW
100.50 |
| NSE 00:00 | 26 Feb | 101.75 |
-0.90 (-0.88%) |
OPEN
101.00 |
HIGH
107.15 |
LOW
100.50 |
| OPEN | 102.20 |
| PREVIOUS CLOSE | 102.70 |
| VOLUME | 154686 |
| 52-Week high | 122.75 |
| 52-Week low | 25.00 |
| P/E | 40.06 |
| Mkt Cap.(Rs cr) | 2,613 |
| Buy Price | 101.50 |
| Buy Qty | 49.00 |
| Sell Price | 101.75 |
| Sell Qty | 456.00 |
Alembic Ltd. (ALEMBICLTD) - Net Profit
Net Profit
| COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Profit (Rs crore) |
| Sun Pharma.Inds. | 595.30 | -14.40 | -2.36 | 3211.14 |
| Dr Reddy's Labs | 4424.60 | -54.65 | -1.22 | 2937.70 |
| Cipla | 786.55 | -22.55 | -2.79 | 2318.17 |
| Aurobindo Pharma | 854.90 | -8.25 | -0.96 | 1872.74 |
| Cadila Health. | 434.75 | -3.05 | -0.70 | 1412.90 |
| Divi's Lab. | 3368.25 | -70.75 | -2.06 | 1372.71 |
| Glenmark Pharma. | 467.00 | -5.55 | -1.17 | 1354.55 |
| Alkem Lab | 2718.60 | -18.05 | -0.66 | 1264.42 |
| Alembic Pharma | 919.15 | 21.35 | 2.38 | 969.40 |
| Torrent Pharma. | 2429.55 | -35.25 | -1.43 | 938.51 |
| Gland Pharma | 2401.50 | -10.20 | -0.42 | 772.86 |
| Lupin | 1018.50 | -4.95 | -0.48 | 727.55 |
| Ipca Labs. | 1849.30 | -16.20 | -0.87 | 652.46 |
| Abbott India | 14396.65 | 48.20 | 0.34 | 592.93 |
| Fortis Health. | 158.45 | -0.60 | -0.38 | 513.33 |
| Pfizer | 4550.70 | -19.85 | -0.43 | 509.13 |
| Natco Pharma | 812.60 | 10.40 | 1.30 | 474.50 |
| Apollo Hospitals | 3060.50 | -30.60 | -0.99 | 470.30 |
| Granules India | 323.40 | -3.25 | -0.99 | 444.07 |
| Ajanta Pharma | 1747.50 | -0.70 | -0.04 | 441.13 |
Quick Links for Alembic:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
